About ReeLabs
ReeLabs is a company based in Mumbai (India) founded in 2009. It operates as a B2C and B2B. The company has 45 employees as of March 31, 2023. ReeLabs offers products and services including Stem Cell Banking, Stem Cell Therapy, and Anti-Ageing Therapy. ReeLabs operates in a competitive market with competitors including NuVasive, Ensoma, StemCyte, Nohla Therapeutics and Immunis, among others.
- Headquarter Mumbai, India
- Employees 45 as on 31 Mar, 2023
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Reelabs Private Limited
- Date of Incorporation 23 Feb, 2009
- Jurisdiction Raigarh, Maharashtra, India
-
Annual Revenue
$2.39 M (USD)14.41as on Mar 31, 2023
-
Net Profit
$297.15 K (USD)64.61as on Mar 31, 2023
-
EBITDA
$596.28 K (USD)60.08as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
45
as on Mar 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ReeLabs
ReeLabs offers a comprehensive portfolio of products and services, including Stem Cell Banking, Stem Cell Therapy, and Anti-Ageing Therapy.
Service for storing stem cells from multiple sources for future treatments.
Treatment using stem cells for diseases like leukaemia and osteoarthritis.
Uses stem cells to address ageing-related conditions and biological testing.
Funding Insights of ReeLabs
Detailed funding history for ReeLabs
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ReeLabs
Investment portfolio details for ReeLabs
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ReeLabs
Detailed financials for ReeLabs
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Reelabs Comparisons
Peer comparison for ReeLabs
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ReeLabs
ReeLabs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NuVasive, Ensoma, StemCyte, Nohla Therapeutics and Immunis, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Smart surgical devices for spinal surgery are developed.
|
|
| Locked | Locked | Locked |
Provider of in vivo stem cell modification technologies and vector-based drug delivery tool
|
|
| Locked | Locked | Locked |
Umbilical cord blood stem cell transplantation and therapeutic products company
|
|
| Locked | Locked | Locked |
Develops stem-cell transplant solutions using umbilical cord blood as an alternative to bone-marrow transplants.
|
|
| Locked | Locked | Locked |
Cell therapies for age- and disease-related immune deficits are developed.
|
|
| Locked | Locked | Locked |
Stem Cell Therapy for the treatment of cardiovascular disease areas
|
Detailed competitors of ReeLabs
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Reelabs
Complete news archive for ReeLabs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ReeLabs
ReeLabs was founded in 2009.
ReeLabs is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
As of Mar 31, 2023, the latest employee count at ReeLabs is 45.
Annual revenue of ReeLabs is $2.39M as on Mar 31, 2023.
ReeLabs specializes in stem cell banking from sources like umbilical cord, amniotic fluid, and placenta, using advanced technology for high cell viability. They provide therapy for diseases such as leukaemia and osteoarthritis, partnering with over 300 hospitals across India. Based in Mumbai, they have served over 100,000 people through innovative regenerative medicine services.
ReeLabs offers Stem Cell Banking, Stem Cell Therapy, and Anti-Ageing Therapy.